98 results
Page 4 of 5
6-K
EX-99.2
5i8cc qd6o
30 Jul 20
Current report (foreign)
7:36am
424B5
pl7q7
20 Jul 20
Prospectus supplement for primary offering
9:21am
6-K
EX-99.1
lvb 4p9z6
20 Jul 20
from 6-K
9:02am
F-3
EX-5.2
q8ei2o5whmgnyvjxcsk1
8 Jul 20
Shelf registration (foreign)
12:00am
F-3
2nk6dgg2do
8 Jul 20
Shelf registration (foreign)
12:00am
6-K
EX-99.3
z2whemmsynqtyjudnpk
21 May 20
Current report (foreign)
8:09am
6-K
EX-99.2
t66z5
21 May 20
Current report (foreign)
8:09am
6-K
EX-99.1
n6fyk o8n0f
21 May 20
Current report (foreign)
8:09am
6-K
EX-99.1
ginr73s79rty1grt
29 Apr 20
InflaRx Reports Full Year 2019 Financial & Operating Results
8:00am
6-K
EX-99.2
yfpmflnmvm9fa0erk
26 Feb 20
InflaRx Announces Positive Initial Data from Ongoing Phase IIa Open Label Study with IFX-1 in Patients Suffering from Pyoderma Gangraenosum
7:15am
6-K
EX-99.2
ib3z3d7ut1p4i8cy6r87
7 Nov 19
Current report (foreign)
7:00am
6-K
EX-99.1
onmew
7 Nov 19
Current report (foreign)
7:00am
6-K
EX-99.3
1om41y
7 Nov 19
Current report (foreign)
7:00am
6-K
EX-99.2
xke2ic2
14 Aug 19
Current report (foreign)
4:16pm
6-K
EX-99.3
1425bxgqshaf63jozl5
14 Aug 19
Current report (foreign)
4:16pm
6-K
EX-99.1
f3f1u9
14 Aug 19
Current report (foreign)
4:16pm
6-K
EX-99.3
7qi6 491u6es2qm
23 May 19
Current report (foreign)
8:00am
6-K
EX-99.1
74zeo2o8zwno
23 May 19
Current report (foreign)
8:00am
6-K
EX-99.2
3afef
23 May 19
Current report (foreign)
8:00am